Literature DB >> 11736908

Vancomycin-induced linear IgA disease with autoantibodies to BP180 and LAD285.

R A Palmer1, G Ogg, J Allen, A Banerjee, K S Ryatt, R Ratnavel, F Wojnarowska.   

Abstract

Linear IgA disease (LAD) is an acquired autoimmune subepidermal bullous disease characterized by the linear deposition of IgA at the basement membrane zone. A minority of cases are induced by drugs, of which the most frequently implicated is vancomycin. The target antigens in idiopathic LAD are heterogeneous, but have not previously been reported in vancomycin-induced LAD. We report three cases, and in two of these we investigated the target antigens. In both we identified IgA antibodies to LAD285 and IgA and IgG antibodies (dual response) to BP180.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11736908     DOI: 10.1046/j.1365-2133.2001.04492.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  8 in total

1.  A 62-year-old man with new-onset bullae.

Authors:  August J Generoso; Jordana A Goldman; Alan H Wolff
Journal:  Allergy Asthma Proc       Date:  2021-03-01       Impact factor: 2.587

2.  Vancomycin-induced Linear IgA Bullous Dermatosis: A Case Report and Review of the Literature.

Authors:  Min Ju Kang; Hyung Ok Kim; Young Min Park
Journal:  Ann Dermatol       Date:  2008-06-30       Impact factor: 1.444

3.  Vancomycin Mediates IgA Autoreactivity in Drug-Induced Linear IgA Bullous Dermatosis.

Authors:  Jun Yamagami; Yoshio Nakamura; Keisuke Nagao; Takeru Funakoshi; Hayato Takahashi; Akiko Tanikawa; Takahisa Hachiya; Toshiyuki Yamamoto; Akemi Ishida-Yamamoto; Toshihiro Tanaka; Noriki Fujimoto; Chikako Nishigori; Tetsuya Yoshida; Norito Ishii; Takashi Hashimoto; Masayuki Amagai
Journal:  J Invest Dermatol       Date:  2018-02-02       Impact factor: 8.551

4.  A Rare Case of Vancomycin-Induced Linear Immunoglobulin A Bullous Dermatosis.

Authors:  Pinky Jha; Kurtis Swanson; Jeremiah Stromich; Basia M Michalski; Edit Olasz
Journal:  Case Rep Dermatol Med       Date:  2017-01-10

Review 5.  Immunoglobulin Disorders and the Oral Cavity: A Narrative Review.

Authors:  Maja Ptasiewicz; Dominika Bębnowska; Paulina Małkowska; Olga Sierawska; Agata Poniewierska-Baran; Rafał Hrynkiewicz; Paulina Niedźwiedzka-Rystwej; Ewelina Grywalska; Renata Chałas
Journal:  J Clin Med       Date:  2022-08-19       Impact factor: 4.964

6.  Eosinophil-rich linear IgA bullous dermatosis induced by mRNA COVID-19 booster vaccine.

Authors:  William J Nahm; Michelle Juarez; Julie Wu; Randie H Kim
Journal:  J Cutan Pathol       Date:  2022-08-03       Impact factor: 1.458

Review 7.  Molecular diagnosis in autoimmune skin blistering conditions.

Authors:  J V Otten; T Hashimoto; M Hertl; A S Payne; C Sitaru
Journal:  Curr Mol Med       Date:  2014-01       Impact factor: 2.222

Review 8.  Immunopathology and molecular diagnosis of autoimmune bullous diseases.

Authors:  Sidonia Mihai; Cassian Sitaru
Journal:  J Cell Mol Med       Date:  2007 May-Jun       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.